Study the mechanism of Treating Male Erectile Dysfunction and that of Inhibition of Phosphodiesterase IV Through Docking and Pharmacophore methodology Based on Tadalafil Derivatives
碩士 === 國立清華大學 === 分子醫學研究所 === 93 === Protein structures and inhibitors of cGMP-specific phosphodiesterase 5 (PDE 5) have been widely studied. A new drug takes a lot time and money from lab to market. With the methodology of computer-aided drug design, it is able to save and decrease time and money i...
Main Author: | 林岳宏 |
---|---|
Other Authors: | Thy-Hou Lin |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/37142069720627049887 |
Similar Items
-
Tadalafil in the treatment of erectile dysfunction
by: Robert M Coward, et al.
Published: (2008-12-01) -
Effect of tadalafil on erectile dysfunction in male patients with diabetes mellitus
by: Popović Srđan, et al.
Published: (2007-01-01) -
Tadalafil therapy for erectile dysfunction following prostatectomy
by: Ateş Kadıoğlu, et al.
Published: (2015-06-01) -
Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
by: Lee LK, et al.
Published: (2016-07-01) -
Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil
by: Amr Abdel Raheem, et al.
Published: (2009-04-01)